ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XSG Xeros Technology Group Plc

1.45
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Xeros Technology Group Plc LSE:XSG London Ordinary Share GB00BMGYBJ57 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.45 1.40 1.50 1.45 1.45 1.45 2,783 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Industrial Patterns 164k -6.93M -0.0459 -0.32 2.19M
Xeros Technology Group Plc is listed in the Industrial Patterns sector of the London Stock Exchange with ticker XSG. The last closing price for Xeros Technology was 1.45p. Over the last year, Xeros Technology shares have traded in a share price range of 1.25p to 4.15p.

Xeros Technology currently has 150,982,535 shares in issue. The market capitalisation of Xeros Technology is £2.19 million. Xeros Technology has a price to earnings ratio (PE ratio) of -0.32.

Xeros Technology Share Discussion Threads

Showing 3351 to 3373 of 3475 messages
Chat Pages: 139  138  137  136  135  134  133  132  131  130  129  128  Older
DateSubjectAuthorDiscuss
03/10/2023
11:40
Looking at Xeros' chart, you'd think it belonged to a hospital patient whose heart monitor had stopped. But could there be a flicker of life in the corpse?

For years it's been trying to flog its washing machine technology with scant success. However, having pitched itself into the future and now changed its business model, is the present now catching up with its technology? Will all the forthcoming global regulation for microplastic-capture save Xeros from the graveyard?

Its overriding negative is the lack of funds. The new CEO has tried to cut costs to preserve the little money it has in its coffers: £2m and it's burning through it at somewhere under £0.5m per month. So it seems Xeros will have to raise more cash and when its market cap is only £4m, any current shareholders will be in for a roasting.

And yet.....the recent Cavendish broker note suggested that real progress was being made with Xeros' Turkish partner, Yilmak, as well as with IFB in India. So much so that it stated: "Our forecasts continue to suggest Xeros has sufficient
cash resource to fund the business into Q2 FY2024E". It added, "We continue to expect month-on-month EBITDA and cash breakeven towards the end of FY2024E." It even added that its forecasts were conservative.

And only yesterday on the webinar, the CEO stated that the company would be announcing "imminently" a partnership agreement with a global clothing brand in conjunction with Yilmak.

Interesting too that Canaccord took a major stake earlier this year. And looking at the CV of the chairman, Klaas de Boer, it's very impressive. Having been the managing partner of Entrepreneurs Fund - which is the largest shareholder in Xeros - he was responsible for investing in a string of young companies and then selling them on. This is a business environment he knows intimately.

So just possibly the risk/reward ratio is starting to turn.

triktrak
01/6/2023
08:11
Sell it all before the inevitable 0
40quidminimum
18/5/2023
10:57
They are paid huge salaries, and the company will never even remotely generate meaningful revenues......and they know it , and have done for years .
hugetakeaway
17/5/2023
19:45
Ivesy7217 May '23 - 15:36 - 3338 of 3338
0 0 1
This company promised so much, but the management should be in prison for theft or incompetence!

tell me more

davemac3
17/5/2023
15:36
This company promised so much, but the management should be in prison for theft or incompetence!
ivesy72
17/5/2023
15:25
Just to let shareholders and prospective investors know that Xeros will be presenting on the 24th of May next week at Mello2023.

We have created a two day physical investor conference (23rd & 24th May) at the Clayton Hotel and Conference Centre in Chiswick that will include 15 top quality keynote speakers, 12 educational workshops and panel sessions, 50 exhibiting companies plus over 80 company presentations for investors to evaluate and understand their current or future investments. For a £25 bonus add-on price delegates at Mello2023 are also invited to make it a three day visit and join us for the Mello2023 Virtual event the day after, Thursday 25th May.

Tickets are still available and if you would like one at half price then enter the code MMTADVFN50.

melloteam
17/5/2023
14:58
Dont be mislead by random comments. Do your own research and reach your own conclusions. Buy, hold or sell on this basis alone. I would recommend anyone to read the various RNSs released over the past year. GLAH
wheeze
17/5/2023
14:24
If you still unlucky enough to hold this,get out on this mini spike...the BOD should be in jail,going to inevitable 0
hugetakeaway
17/5/2023
11:55
Meaningless RNS with no actual figures or forecasts, just spiel.

Surely they don't need to raise again already?

glavey
28/4/2023
18:47
Indeed .Going to ZERO.
nowthatswhaticallmusic
28/4/2023
10:28
STRONG SELL
jpuff
28/4/2023
10:27
A good question for the AGM might be when are they going to sell anything to justify the huge salaries of this Lifestyle company?
jpuff
24/4/2023
21:07
How does it capture micro fibres when the unit is installed inside the detergent drawer, as per video ?
1pencil
24/4/2023
20:49
Video from Thursday's Proactive investor event now available:
timbo003
19/4/2023
20:17
Just look at the last 4 years and what XSG have come up with its all rubbish, it's just a lifestyle company constantly trying to shaft new investors, the directors should be locked up.
beerboy02
18/4/2023
17:54
I wonder how much longer it can survive? Given no (paltry) revenues?
jpuff
18/4/2023
15:21
Problem numero uno are admin expenses. By end of 2023 another fundraising will be required.
marmar80
18/4/2023
12:37
890,000k mkt cap ...200,000k rev, profit forget it ...buying the revenue ...pointless
amanitaangelicus
18/4/2023
08:52
As I said, still dropping like a stone
jpuff
18/4/2023
08:06
Morning sweet cheeks, any fantasy shorts on this one, huh?
orkneyarab
18/4/2023
08:03
200k revenue? Flip me...money extraction scheme in operation ...only mugs need apply.
amanitaangelicus
18/4/2023
07:20
“Solid progress” huh.

I’d hate to see what not doing well looked like with these clowns. Revenue down. Losses up. Admin costs up. Cash draining out of the business.

Financial summary

· Revenue of £0.2m (2021: £0.5m).

· Adjusted EBITDA1 loss of £7.4m (2021: loss £6.3m).

· Administrative expenses of £7.5m (2021: £7.2m).

· Net cash outflow from operations increased by 19.7% to £7.0m (2021: £5.8m). Cash at 31 March 2023 £4.5m.

· Delays in domestic Care launch affect forward looking revenue mix across 2023 and 2024, with revenue lower than previously forecast.

terminator101
14/4/2023
10:19
Results next Tuesday and Investor Meet presentation next Thursday.

Good opportunities to spell out the huge potential with the new distribution agreements.

someuwin
Chat Pages: 139  138  137  136  135  134  133  132  131  130  129  128  Older

Your Recent History

Delayed Upgrade Clock